0001127602-23-019612.txt : 20230630
0001127602-23-019612.hdr.sgml : 20230630
20230630160451
ACCESSION NUMBER: 0001127602-23-019612
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221202
FILED AS OF DATE: 20230630
DATE AS OF CHANGE: 20230630
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Romanelli Joseph
CENTRAL INDEX KEY: 0001938322
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06571
FILM NUMBER: 231061657
MAIL ADDRESS:
STREET 1: 126 EAST LINCOLN AVENUE
CITY: RAHWAY
STATE: NJ
ZIP: 07065
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merck & Co., Inc.
CENTRAL INDEX KEY: 0000310158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221918501
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
BUSINESS PHONE: 908-740-4000
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
FORMER COMPANY:
FORMER CONFORMED NAME: Merck & Co. Inc.
DATE OF NAME CHANGE: 20091103
FORMER COMPANY:
FORMER CONFORMED NAME: SCHERING PLOUGH CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0407
4
2022-12-02
0000310158
Merck & Co., Inc.
MRK
0001938322
Romanelli Joseph
MERCK & CO., INC.
126 EAST LINCOLN AVENUE
RAHWAY
NJ
07065
1
President, Human Health Int?l
0
Common Stock
2022-12-02
4
P
0
59
109.67
A
59
I
By Spouse
Common Stock
2022-12-05
4
P
0
107
109.54
A
20391.325
D
Common Stock
2022-12-06
4
P
0
30
109.39
A
20421.325
D
Common Stock
2022-12-13
4
P
0
56
110.96
A
20477.325
D
Common Stock
2022-12-19
4
P
0
7
109.04
A
20484.325
D
Common Stock
2023-02-21
4
P
0
11
109.20
A
20495.325
D
Common Stock
2023-03-20
4
P
0
136
105.47
A
20631.325
D
Common Stock
2023-03-24
4
S
0
35
104.65
D
20596.325
D
Common Stock
2023-04-26
4
P
0
3
113.68
A
20599.325
D
None of the purchases or sales reported herein were directed by the reporting person, but were executed by a brokerage firm for the benefit of the reporting person's managed account, without the reporting person's knowledge. One of the reported transactions resulted in a short swing profit under Section 16(b) of the Securities Exchange Act of 1934, as amended ("Section 16(b)"), and the reporting person has disgorged $374.01 to the Issuer, which amount represents all profits related to these transactions in accordance with Section 16(b).
/s/ Jon Filderman, attorney-in-fact for Joseph Romanelli
2023-06-30